“Generative AI” and digital cancer care

Generative Artificial Intelligence (or “GenAI”) has been at the centre of interest in recent times. It represents a specific “flavour” of Artificial Intelligence where analysis and composition are combined to create content (for humans or machines).

The applications of GenAI in cancer care are evolving around content generation for patients and clinicians. For example, personalized cancer treatment plans can be created, through analysis of electronic health records (EHRs), patient reported outcomes (PROs), guidelines and other inputs. The use of friendly language and relevant terminology for the results are both goals that the technologies have been evolving towards – with promising results for the future of digital cancer care.

Impact for patients

GenAI can really have a strong impact on cancer patient care. The important part, however, is for patients to be able to make their own contributions in order to receive personalised and relevant material.

Impact for clinicians

Clinicians have been increasingly adopting GenAI for summarising research findings and even patient records. The interest has been growing but also so has scrutiny – which is reasonable and important for the evolution of such a cutting-edge technological development

The IMPORTANT study

Although the IMPORTANT study has not been designed to utilise GenAI or such technologies, its data-centric and highly decentralised approach allows it to leverage such innovations if and as required and appropriate.

Summary

Generative Artificial Intelligence (“GenAI”) is here to stay. Patients with cancer stand to benefit from leveraging their data in a much more enhanced way than before. Similarly, clinicians can save time and effort while technology can bring to the forefront patterns that would otherwise have been overlooked.